Mark Lewis: Consider Olanzapine for chemotherapy-induced nausea/vomiting
Mark Lewis posted on X/Twitter about a recent paper by Jyoti Bajpai et al., commenting:
“I am once again asking you to consider prescribing olanzapine for patients experiencing chemotherapy-induced nausea/vomiting
* it’s an effective antiemetic
* it can enable better sleep (but less daytime somnolence at 2.5mg vs. 10mg)
* it can boost mood.”
Journal: The Lancet Oncology
Author: Jyoti Bajpai, Venkatesh Kapu, Sushmita Rath, Sravan Kumar, Anbarasan Sekar, Priyanka Patil, Altaf Siddiqui, Srikanth Anne, Akash Pawar, Sujay Srinivas, Prabhat Bhargava, Seema Gulia, Vanita Noronha, Amit Joshi, Kumar Prabhash, Shripad Banavali, Rajiv Sarin, Rajendra Badwe, Sudeep Gupta
Mark A. Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent & young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023